Sign in
4

Changes in Ownership

NEUROONE MEDICAL TECHNOLOGIES Corp Filed Acc 0001596771-19-000134

Options or other derivatives

  • CEO and President acquired 500,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Rosa David A · CEO and President

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2019-11-05 Grant or award : show line 1 in the form Option to Purchase Common Stock +500,000 $2.14 2029-11-05 500,000 500,000 D
Loading xslF345X03/primary_doc.xml…